The Wisconsin lawmaker has been a supporter of Pierre Kory, a controversial physician who advocated for a "wonder drug" ...

With President Donald Trump labeling the media “the enemy” and threatening broadcast licenses and political enemies, First Amendment scholars are asking:  Is the First Amendment under more ...

The coming era of biosecurity will demand a broader and more adaptive approach as AI, powerful biological engineering ...

The U.S. Food and Drug Administration announced the approval of the first hematopoietic stem cell transplant therapy to treat ...

For decades, women’s health has been under-researched and misunderstood in the scientific and medical communities. This ...

From claims that vaccines don't work to manipulated images and deliberately misrepresenting what politicians say, social ...

Dr. Hein was drawn to the natural history of misinformation through his research on fish. He and his colleagues observed the ...

Dispersing federal research funding, largely concentrated at private universities on the coasts, to the rest of the country ...

A year of new treatments, new technologies, new ways to stay safe during disasters and new insights on the mysteries of the ...

Amid NIH funding delays, reversals and uncertainty, a scientist at Harvard who studies breast cancer has lost one-third of her lab employees and wonders if she can continue her research experiments.

Words reflecting diversity language have appeared less frequently in grants awarded by the National Institutes of Health (NIH) since the 2024 US presidential election, with a 25% relative decrease ...

The AI trade remains intact as Nasdaq weakness signals consolidation, value rotation builds, and long-term AI budgets grow.